Track 5: Patient Engagement
This track, composed of a myriad of sessions, is themed, Operationalizing Patient Engagement, and Concepts of Meaningful Patient Engagement. It will address meaningful patient engagement in medical product development, from early product development, and approval, through maintenance phases. It focuses on important questions for all stakeholders, including:
- How do we meaningfully engage patients and incorporate their voices into decision-making throughout the medical product lifecycle?
- How do we become truly patient- (and people-) centric in our approach?
- How do we operationalize patient-centric approaches in our day-to-day work?
- How can we measure the effectiveness of our efforts, both for patient outcomes and to meet the needs of other stakeholders such as industry and regulatory decision-makers?
- What have we learned that can be used to drive more meaningful patient engagement?
- How do stakeholders best work together to leverage their collective power and expertise to promote meaningful involvement of patients?
Sessions in Patient Engagement
Sunday, June 23 | Short Courses
- Protocol Co-Design with Patients and Advocates
- Patient Literacy 101: Practical Strategies for Improving Your Patient Materials
- Patient Preferences: Using Conjoint Analysis and Stated Preferences in Drug Development and Regulatory Decision-Making
Monday, June 24
- Collecting Better Patient Experience Data: Lessons Learned from Patient Organizations
- Show me the Money! Patient and Caregiver Roles and Compensation in Research, Development, and Innovation
- Making Trials Work for Special Populations
Tuesday, June 25
- Patient Focus as Part of the Regulatory Affairs DNA: Opportunities and Challenges
- Walking the Talk: Using Home Nursing as a Patient-Centric Service in Clinical Trials - From Multiple Perspectives
- Our Doors are Open! Pathways and Programs for Patient Stakeholders to Engage with FDA
- Patient Experience Data: How Could this Data Enhance Decision-Making at Different Stages of Medical Product Development?
- Impact of Patient Engagement on the Biopharmaceutical Industry's Business and Organization
- Measuring the Impact of Patient Engagement Activities in Medicines R&D: A Way to Sustain the Cultural Change?
Wednesday, June 26
- Identifying High-Value Patient Engagement Opportunities: A Collaborative Three-Step Process for Sponsors and Patient Groups
- Understanding and Exploring Elements of a Patient-Focused Product Launch
- Patient Engagement Quality Guidance: Results and Learnings from Global Multistakeholder Pilots
- Patient Preferences in Decision-Making and the PREFER Project: Past, Present, and Future
- On the Soapbox: Good for People and Good for Research: Individuals as Research Partners
Thursday, June 27
View one of our video interviews from DIA 2018 with Kathleen Maxian, founder of the Ovarian Cancer Project, who attended DIA 2018 as a Patient Scholar where she shared the mission, the vision, and other insights into the work of the Ovarian Cancer Project.
Who is This Track Designed For?
Professionals involved in: patient affairs, patient advocacy, patient groups, patient support services, medical affairs (including CMOs and MSLs), clinical trial design and optimization, clinical research and operations, regulatory affairs, regulatory agency, corporate and government affairs, safety and pharmacovigilance, outcomes research, epidemiology, and Health Technology Assessment..